SPECT and PET Radiopharmaceuticals
2,100
Radiopharmaceuticals Prepared and Distributed Daily
230
Hospitals and Independent Health Facilities Served
100,000
Containers Shipped Annually
600,000
Patients Scanned with our Radiotracers Annually
Testimonials
“We are incredibly grateful to Isologic for their exceptional support and partnership. After an unexpected power outage left us unable to use several doses, Isologic went above and beyond by generously covering the loss. This extraordinary gesture highlights their commitment to their clients and the strength of our partnership. Thank you for standing with us during this challenge!”
—Daniel I. Nasser, KMH Cardiology Centres.
“The collaboration between Isologic and the Canadian Association of Nuclear Medicine (CANM) is essential to ensuring that nuclear medicine physicians across Canada have access to critical isotopes for diagnostic and therapeutic procedures. Their commitment to reliable distribution directly impacts patient care, making a real difference in the lives of those who rely on these vital medical advancements.”
— Nicolas Rondeau Lapierre, General Manager, CANM
“I would like to thank Isologic customer service for their exceptional support. Your assistance with providing Isologic Pyrophosphate cold kits for Thunder Bay Regional is a game changer since room temperature storage ensures patients no longer need to travel for Tc-PYP scanning. This is collaboration at its finest”
—Brad Plain, Peterborough Regional Health Centre (PRHC)
News
ISOLOGIC Unveils One of Canada’s Most Advanced Nuclear Medicine Facilities
MONTREAL, Sept. 2, 2026
ISOLOGIC Innovative Radiopharmaceuticals officially inaugurated its new Lachine facilities yesterday, Tuesday, September 1, during a ribbon-cutting ceremony attended by employees, partners, clients and elected officials. The $30-million investment…
ISOLOGIC makes $29,9 million investment in advanced isotope production facility in Quebec
Montreal, June 4, 2024 – ISOLOGIC Innovative Radiopharmaceuticals is investing $29,9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope supply chain as...
ISOLOGIC Launches Illuccix™ PSMA PET Imaging Agent to Detect Prostate Cancer
Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix™, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate...
